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Abstract
Objective: The purpose of this study was to investigate the rat skin penetration abilities of two commercially
available low-level laser therapy (LLLT) devices during 150 sec of irradiation. Background data: Effective LLLT
irradiation typically lasts from 20 sec up to a few minutes, but the LLLT time-profiles for skin penetration of light
energy have not yet been investigated. Materials and methods: Sixty-two skin flaps overlaying rat’s gastroc-
nemius muscles were harvested and immediately irradiated with LLLT devices. Irradiation was performed
either with a 810 nm, 200mW continuous wave laser, or with a 904 nm, 60mW superpulsed laser, and the
amount of penetrating light energy was measured by an optical power meter and registered at seven time points
(range, 1–150 sec). Results: With the continuous wave 810 nm laser probe in skin contact, the amount of pene-
trating light energy was stable at *20% (SEM – 0.6) of the initial optical output during 150 sec irradiation.
However, irradiation with the superpulsed 904 nm, 60mW laser showed a linear increase in penetrating energy
from 38% (SEM – 1.4) to 58% (SEM – 3.5) during 150 sec of exposure. The skin penetration abilities were sig-
nificantly different ( p < 0.01) between the two lasers at all measured time points. Conclusions: LLLT irradiation
through rat skin leaves sufficient subdermal light energy to influence pathological processes and tissue repair.
The finding that superpulsed 904 nm LLLT light energy penetrates 2–3 easier through the rat skin barrier than
810 nm continuous wave LLLT, corresponds well with results of LLLT dose analyses in systematic reviews of
LLLT in musculoskeletal disorders. This may explain why the differentiation between these laser types has been
needed in the clinical dosage recommendations of World Association for Laser Therapy.
Introduction
Lasers are used for a number of different purposes inmedicine. Class 4 surgical lasers are used to cut and de-
stroy biological tissue, whereas low-level laser therapy
(LLLT) is administered with weaker class 3B lasers and mean
output powers (MOP) < 500mW.1 The most commonly used
lasers in LLLT are gallium-aluminum-arsenide (GaAlAs) with
a wavelength of 810 nm ( – 50 nm) operating in continuous
output mode, and gallium-arsenide (GaAs) with a wave-
length of 904 nm superpulsed with high peak power pulses.
LLLT emerged as a treatment option in clinical practice
approximately three decades ago.2 After the initial upsurge,
LLLT gained a poor reputation because of a string of negative
research results being published. This picture has slowly
changed again as an increasing amount of evidence is point-
ing toward the existence of specific therapeutic windows for
LLLT. Several studies have found that anticipated optimal
doses yield significantly better results in tendinopathies,3 os-
teoarthritis,4 and neck pain.5
The skin is the body’s external boundary in animals and
humans. Among other things, the skin serves as a barrier
against physical and chemical intrusions.6 The skin also
represents a barrier to applied physical energy from
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electrophysical agents (EPAs), which represent one of the
four treatment pillars of physical therapy.7
EPAs are used to treat tissue such as muscles, tendons,
ligaments, and joint capsules. This makes the skin barrier of
particular interest for research on EPAs. Variation charac-
teristics in the biophysical ability to penetrate skin have di-
rect implications for the dosing of LLLT in clinical settings.
EPA therapy dosing has historically been based on clinical
experience, rather than solid scientific evidence from basic
research.8
The skin’s photoprotective properties, during epidermal
light reflectance and melanocytes light absorption, avoid
tissue injury caused by radiation from sunlight.9,10. The skin
penetration characteristics of ultraviolet and visible light, are
fairly well mapped in biophysical and dermatological liter-
ature. However, this literature provides only limited data
about the penetration ability of the most commonly used
infrared and near-infrared LLLT wavelengths in clinical
settings.
Biophysically, the ability of lasers to penetrate tissue is
dependent upon the laser’s wavelength. Light with a wave-
length range of 700–1000 nm is infrared and invisible, and
penetrates tissue better than light in the red wavelengths
(600–700 nm).11 Clinically, laser irradiation in skin flaps has
shown that penetration increases linearly with wavelengths
from 450nm to 1030 nm.12 This was further supported by
results from a study of two different red laser wavelengths in
human skin flaps, which showed that a wavelength of 675 nm
penetrated better than did a wavelength of 632.8 nm.13 Other
studies have reported similar findings with wavelength-
dependent penetration in animal tissue.14 These results cor-
relate well with another study showing that a greater amount
of energy penetrated rabbit skin with a wavelength of 904 nm,
than with a red wavelength of 632.8 nm.15
In a systematic review of LLLT studies on lateral epi-
condyle tendinopathies, Bjordal et al.3 found effective doses
from superpulsed 904 nm lasers to be significantly lower
than effective doses from 632.8 nm lasers. Guidelines from
World Association for Laser Therapy (WALT) have also
differentiated between wavelengths. Typically, WALT rec-
ommends doses that are twice as high for lasers within the
780–860 nm wavelength range, than for lasers with a wave-
length of 904 nm.16 WALT guidelines doses are derived from
some 160 published randomized controlled LLLT trials. The
difference in energy dose can only partly be explained by
wavelength, which typically accounts for < 20% of the pen-
etration difference.12 However, a satisfactory causal under-
standing of the need for differentiated dosing is still lacking.
An aspect other than wavelength dependency is the mode of
operating the laser. GaAs lasers with 904 nm wavelength
operate with strong, short pulses (peak power 10–100W) in a
superpulsed mode with nanosecond or picosecond pulse
durations, whereas 780–860 nm GaAlAs lasers typically op-
erate in a continuous mode or with chopped pulses (peak
power < 0.5W). This feature has not been extensively ad-
dressed in the LLLT literature, and few studies have com-
pared continuous with pulsed and superpulsed irradiation.
In a recent article, Hamblin et al.17 searched the literature for
possible differences in therapeutic effects between those of
continuous and pulsed laser irradiation. Their conclusion
was that pulsed irradiation mode seems to be superior to
continuous mode. However, this result could also be caused
by differences in laser parameters other than irradiation
modes, as no head-to-head comparisons were performed
with equal doses. Moriyama et al.18 compared superpulsed
with continuous irradiation mode from 905 nm lasers in
acute knee inflammation in mice induced by Zymosan-A,
and found more pronounced upregulation of inducible nitric
oxide synthase (iNOS) from superpulsed irradiation mode.
They suggested that inflammatory pathway responses were
activated by different mechanisms in superpulsed and con-
tinuous irradiation modes.
The few existing LLLT studies that deal with penetration
issues have focused either on energy loss19,20 or on pene-
tration depth.13,15 In LLLT treatment, an irradiation dose is
typically administered during periods lasting from 20 to
30 sec up to a few minutes. No studies have yet investigated
the time-profiles for skin penetration of energy from LLLT
devices. With this perspective, we decided to perform a
study with two commonly used lasers in LLLT.
Aim
The aim of this study was to investigate the rat skin
penetration abilities of two commercially available LLLT
lasers during 150 sec of exposure.
Materials and Methods
Materials
Thirty-four matured male Sprague–Dawley rats weighing
250–300 g were housed with 3–4 animals together in indi-
vidually ventilated cages. Light cycles were kept at 12+/
12- h, with water and food ad libitum. The animals were
then euthanized and 62 skin flaps (n = 62) overlaying the
gastrocnemius muscles on the hind legs were successfully
dissected free and irradiated within 3min after euthaniza-
tion. Six skin flaps were discarded because of human errors
in the dissection procedure.
Instruments
The laser MOPwasmeasured with an Optical PowerMeter
System (Thorlabs Instruments, U.K.). The Optical Power
Meter System consists of a PM100 Display unit with sample
rate of 6Hz and accuracy of – 1%, and a S121B silicon sensor.
The S121B sensor input had an aperture with diameter of
O = 9.5mmwith an optical power range 500 nW–500mW and
an accuracy of – 5% (manufacturer’s specification).
Two commercially available therapeutic lasers were used
for laser irradiation: (1) 810 nm wavelength laser (Thor-DD,
U.K.), operated in a continuous mode with MOP of 200mW,
spot size 0.0314 cm2, and power density of 6.37W/cm2
(manufacturer’s specification); and (2) 904 nm wavelength
laser (Irradia, Sweden) operated in a superpulsed mode: Peak
power 20W, superpulsed width 100 ns (10 - 9 sec) with a fre-
quency of 6 kHz; and 60mW MOP, spot size 0.0364 cm2, and
power density 1.67W/cm2 (manufacturer’s specification).
Experimental procedure, part 1
Step one: energy output measured directly. The two
lasers were tested for MOP during 150 sec of exposure with
no obstacles between the laser source and the Optical Power
Meter.
SKIN PENETRATION WITH LLLT 689
Page 2 of 7
(page number not for citation purpose) xxx
Step two: energy output measured after penetrating a
plastic film. The two lasers were tested for MOP during
150 sec of exposure with a transparent plastic film between
the laser source and the Optical Power Meter.
Step three: energy output measured after penetrating
freshly harvested rat skin flaps. with the probe in skin con-
tact. The animal was put into gas anesthesia (isoflurane,
Isoba), and then given 0.4mL intraperitoneal anesthesia
(Mebumal 50mg/mL). Hair was shaved from both hind legs.
Experimental procedure, part 2
Animals were then euthanized by cardiac arrest from a
1mL saturated potassium chloride solution.
The skin overlaying the gastrocnemius muscle was then
dissected free: distally from calcaneus, anteriolateral and
anteriomedial of the edge of the gastrocnemius muscle, and
proximal to the gastrocnemius muscle (Fig. 1).
The Optical Power Meter System was tuned to the same
wavelengths as the respective test lasers.
All skin flaps were then irradiated in a sequential manner
with increasing exposure times for each laser.
For every skin flap the measurement procedure started
with registering the lasers’ MOP directly into the Optical
Power Meter. A plastic film was then placed over the sensor.
The skin flap was then placed on the plastic film and the
laser MOP was registered. During the exposure, the laser
probe was in full skin contact for 150 sec. The laser probe was
held in skin contact with slight pressure necessary to main-
tain the probe in a fixed position. The therapist sought to
apply the same amount of pressure for all skin flaps. Laser
penetration through the skin plus plastic film was registered
at seven time points; immediately after being activated, after
10 sec, after 30 sec, and then every 30 sec up to 150 sec.
Step four (same procedure as in step three, but with
the probe not in skin contact). The laser probe was now
kept *1mm from the skin during LLLT irradiation.
Main outcome measure
The power was measured in mW without obstacles after
penetration through air, plastic film, and rat skin flap, and as
a percentage of the measured nominal MOP.
Statistical analysis
Statistical differences were calculated by Statistical Pack-
age for the Social Sciences (SPSS, v.19) using repeated mea-
sures ANOVA, generalized estimating equations(GEE), for
the whole sequence (measurements at 10 sec are omitted in
these calculations). Microsoft Excel (Microsoft Office Excel
2007) was used for statistical descriptive analysis, Student’s
t-test p-value significant differences, and graphs.
Ethical approval
This study was approved by the local animal laboratory
committee at the University of Bergen, Norway (Appl. No.
20102676).
Results
Step one (no obstacle, through air only)
The MOP from both lasers were stable during 150 sec of ex-
posure. The904nmlaser increasedMOPby 0.3mW(SEM–0.4),
whereas the 810nm laser reduced MOP by 9.8mW (SEM–1.9)
by the end of 150 sec of exposure (Table 1). The statistic GEE
estimated a slope of 0.25mW per 30 sec (95%CI: 0.07 to 0.42,
p<0.01) for the 904nm laser; and a slopeof -1.14mWper 30 sec
(95%CI: -1.44 to - 0.84, p<0.01) for the 810nm laser.
Step two (through plastic film)
The plastic film reduced MOP by 3.6%, or 2.3mW
(SEM – 1.2), on average from the 904 nm laser; and by 6.6%,
or 12.7mW (SEM – 1.0), on average from the 810 nm laser
(Table 1). The statistic GEE estimated a slope of 0.16mW per
30 sec (95%CI: - 0.10 to 0.42, p= 0.23) for the 904 nm laser;
and a slope of - 1.00mW per 30 sec (95%CI: - 1.49 to - 0.52,
p < 0.01) for the 810 nm laser.
Step three (through skin, probe in skin contact)
The two lasers had statistically different skin penetration
abilities. The percentage of energy penetrating skin from the
810 nm laserwas stable at* 20%ofMOP (ranging from 19.5%
[SEM – 0.6] to 20.4% [SEM– 0.6]) during the exposure period
(Table 1). The statistic GEE estimated slope was - 0.26% of
MOP per 30 sec (95%CI: - 0.35 to - 0.17, p< 0.01), whereas the
percentage of energy penetrating skin from the 904 nm laser
increased almost linearly during the exposure period, from
38.7% of MOP (SEM – 1.4) to 58% of MOP (SEM – 3.5) (Table
1). The statistic GEE estimated slope was 2.29% per 30 sec
(95%CI: 1.69 to 2.88, p < 0.01) for the 904 nm laser.
Comparing the percentage of MOP penetrating skin from
the two lasers, there were significant (t-test, p < 0.01) differ-
ences at all measured time points (Table 1 and Fig. 2).
Step four (through skin, probe not in skin contact)
Both lasers showed the same trends of energy penetrating
skin as was the case with the laser probes in skin contact.
There were significant (t-test, p < 0.01) differences in per-
centage of MOP penetrating skin from the two lasers at all
FIG. 1. A skin flap, consisting of skin overlaying the gas-
trocnemius muscle.
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measured time points (Table 1), even though the slope of
increased penetration during processing time from the
904 nm laser was smaller than with the probe in skin contact.
The statistic GEE estimates a slope of 1.42% of MOP per
30 sec (95%CI: 0.82 to 2.03, p< 0.01) with the probe not in skin
contact. In percentages, the amount of energy penetrating
skin increased from 36.8% (SEM – 2.4) to 44.4% (SEM – 3.0)
during exposure (Table 1 and Fig. 2).
In skin contact versus not in skin contact
and probe’s shape
For the 810 nm laser, the amount of energy penetrating the
skin was slightly higher during irradiation than with the
probe in skin contact: The percentage of MOP was *24%
(ranging from 23.1% [SEM – 1.7] to 25.5% [SEM – 2.2]) during
the exposure period with the probe not in skin contact (Table
1 and Fig. 2).
The statistic GEE estimated slope was - 0.42% of MOP per
30 sec (95%CI: - 1.27 to 0.43, p= 0.33).
Irradiation with the laser probe in skin contact versus not
in skin contact resulted in a change in skin penetration for
both lasers. This change was most likely not attributed to
laser parameters, but to the different physical shape of the
two probe tips. The 904 nm laser probe has a protruding
convex lens, which squeezes the skin when the probe is in
skin contact. This will cause better penetration with full skin
FIG. 2. Percentage of mean output powers
(MOP) (– SEM) penetrating skin during
150 sec of irradiation, from the 904 nm
(60mW, superpulsed) laser and the 810 nm
(200mW, continuous) laser. Data are re-
presented with the laser probe in skin contact
and not in skin contact.
Table 1. Skin Penetration with LLLT Devices. Penetration Time-Profile for Continuous 810nm
and Superpulsed 904nm Wavelength Lasers in a Rat Model
Exposure time (in seconds):
n 1 10 30 60 90 120 150
Direct (through air)
904 nm (mW) 5 64.7 64.3 64.2 64.4 64.6 64.8 65.0
(SEM– ) 0.2 0.2 0.5 0.4 0.4 0.4 0.4
810 nm (mW) 8 198.3 195.5 192.9 191.2 189.7 189.3 189.5
(SEM– ) 1.8 2.1 2.0 1.8 1.8 2.2 1.9
Through plastic film
904nm (mW) 5 61.6 61.6 62.1 62.8 62.6 62.3 62.6
(SEM– ) 1.6 1.4 1.2 1.2 1.0 0.8 0.8
810 nm (mW) 7 185.5 182.8 180.1 178.4 177.4 176.5 175.7
(SEM– ) 0.7 0.8 1.0 1.2 1.2 0.9 1.3
Skin penetration (through plastic film and skin)
Probe in skin contact
904 nm (% of MOP) 62 38.7 42.0 45.1 47.0 54.7 56.3 58.0
(SEM– ) 1.4 1.6 1.8 1.9 3.4 3.5 3.5
810 nm (% of MOP) 62 20.4 20.1 19.9 19.5 19.9 19.8 19.8
(SEM– ) 0.6 0.7 0.7 0.6 1.3 1.2 1.3
t-test ( p) 1.30E-19 1.01E-20 5.58E-21 1.74E-22 3.33E-11 2.70E-11 1.04E-11
Probe not in skin contact
904 nm (% of MOP) 15 36.8 37.6 38.6 41.2 43.6 43.4 44.4
(SEM– ) 2.4 2.8 2.8 3.2 3.3 2.9 3.0
810 nm (% of MOP) 9 25.5 25.5 25.5 24.3 24.4 23.1 23.7
(SEM– ) 2.2 2.0 1.8 1.8 1.8 1.7 1.5
t-test ( p) 3.91E-03 5.92E-03 3.10E-03 1.42E-03 0.46E-03 0.01E-03 0.44E-03
The mean energy output from two commercial LLLT-lasers, during 150 sec of irradiation: direct into an Optical Power Meter, through
plastic film, and through plastic film plus skin (with the LLLT-probe in skin contact and not in skin contact).
LLLT, low-level laser therapy; MOP, mean output powers.
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contact than with no skin contact. On the other hand, the
810 nm laser probe has a recessed flat window. Here, the
metallic ring surrounding the lens will push skin underneath
the lens, which leads to less penetration with the probe in
skin contact than not in skin contact (Fig. 3).
Discussion
The skin barrier has been a major obstacle for EPAs since
they were introduced in the treatment of tissue pathology.21
Questions such as how deep can different energy forms
penetrate into the body, and what happens in terms of en-
ergy loss in this process has intrigued researchers for de-
cades. LLLT has poor penetration ability when compared
with other energy forms such as electromagnetic and ultra-
sound radiation. Nonetheless, it is important to emphasize
that the current study demonstrates that between 20 and 58%
of the energy delivered to the skin surface is penetrating the
rat skin barrier during LLLT irradiation. The important
conclusion is therefore that this residual energy should be
more than enough to reach the dose threshold for stimulat-
ing physiological and tissue repair processes.
The first two steps of the experimental procedure devel-
oped as expected, showing that both lasers delivered stable
MOP, and that energy loss in a plastic film was negligible
and stable. The time-profiles for skin penetration, during
150 sec of exposure, were, however, distinctly different for
the two lasers. For the 810 nm continuous laser, the pene-
tration ability stayed at the same level during 150 sec of
exposure, whereas the penetration from the 904 nm super-
pulsed laser increased in an almost linear manner during
150 sec of exposure. The higher skin penetration ability of the
904 nm superpulsed laser increased from + 18% initially to
+ 28% at 150 sec of exposure. This time-profile of increased
skin penetration ability during exposure time has, to our
knowledge, never been demonstrated before. The pronounced
differences cannot be explained by different wavelengths
alone. According to studies investigating the ability of dif-
ferent wavelengths in light to penetrate skin, a difference of
1022 to 15%,23 could be expected between the wavelengths
800 nm and 900 nm. This leads us to speculate that the irra-
diation mode is the most likely source for the observed dif-
ferences in skin penetration. It has previously been suggested
that strong pulses may cause a photobleaching effect in the
skin barrier over time.24
In the research for identification of possible LLLT dose-
response patterns, we suggested already in 2001 that the
different laser wavelengths and irradiation modes should be
classified in different categories.25 At that time, the differ-
entiation was governed more by minimizing uncertainty
than by solid evidence for these possible differences.
Our current findings contributes to a plausible explanation
for different effective doses from 904nm and 780–860 nm
lasers, found in clinical studies and reflected in WALT
guidelines.16 It can be illustrated by an example with two
60mWMOP lasers, that WALT recommendations of twice as
high doses for 810 nm lasers than for 904 nm lasers, as they
result in approximately equal amount of energy penetrating
the skin. A dose of 4 J from an 810 nm, 60mW, continuous
laser, takes 67 sec to deliver. The skin penetration rate with
the probe in skin contact is 20%. The cumulated amount of
energy penetrating skin is 0.8 J ( = 20% · 0.06W · 67 sec). The
delivering of a 2 J dose from a 904 nm, 60mW, superpulsed
laser, takes 33 sec. With the probe in skin contact, skin pen-
etration increase linearly from 38 to 45% during 30 sec of
exposure (percentages are in accordance with Table 1). The
amount of energy penetrating skin cumulates to 0.82 J
f¼ [(38% · 0:06WÞþ (½ · [45 38%]· 0:06W)] · 33 secg
In line with our currently demonstrated skin penetration
profile, Castano et al.26 found long processing time from
superpulsed 810 nm lasers to be more effective than short
processing time in inflammatory rat knee arthritis. In
Castano’s study, all other irradiation parameters were held
equal.
In a study with LLLT intervention in induced arthritis in
mouse knees, Moriyama et al.18 found irradiation mode to
activate iNOS expression differently. They suggested differ-
ent mechanisms in activating the inflammatory pathway
response as an explanation to the significant differences
found between superpulsed and continuous irradiation
mode from 905nm lasers. In perspective of our current
findings, the amount of energy penetrating skin from su-
perpulsed lasers is more than double the amount of energy
from continuous lasers, during 200 sec of exposure. These
circumstances could as well be part of the given reason.
This skin penetration profile, with a linear increase in
amount of energy passing skin during an irradiated dose
from the superpulsed laser, points out processing time as an
interesting parameter in LLLT with superpulsed lasers.
In most clinical studies on animals, LLLT irradiation is
initiated hours after an injury or injection. In Moriyama’s
study with increased inflammatory reactions in mouse knees
after LLLT, the treatment from a superpulsed laser was
15min after induced inflammation. Similarly, we found
increased edema in rat Achilles tendon treated with 3 J from
a superpulsed laser within 30min after a blunt trauma.27
Whether these increased inflammatory reactions are caused
FIG. 3. Laser probe tip, the 904 nm laser with a protruding
lens (left), and the 810 nm laser with a folded up lens (right).
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by too early irradiation after induced injury, or whether the
amount of energy penetrating the skin gave a too high dose,
is unclear. We need further research on initiation of irradia-
tion and influence of irradiation mode to answer those
questions.
Conclusions
In clinical practice, the different skin penetration profiles
for superpulsed and continuous lasers will have some clini-
cal implications. In addition to different optimal doses as
reflected in WALT guidelines, the penetration profile influ-
ences skin temperature during LLLT treatment. We found
lower thermal effects in dark skin from 904 nm superpulsed
laser than from 810 nm continuous laser in one of our earlier
studys.28 This difference in thermal effects from these two
lasers can be explained by skin penetration profile. The
percentage of energy absorbed in skin during processing
time is decreased for superpulsed lasers, whereas it is con-
stant for continuous lasers. In addition, 904 nm superpulsed
lasers have better skin penetration initially than do 810 nm
continuous lasers (Fig. 2).
Other critical features with the lasers, which are outside
the scope of this study, are to what degree output power
(peak value), power density (mW/cm2), and spot size (cm2)
influence skin penetration.
Other important questions, are ‘‘What happens to the skin
during LLLT irradiation?’’ and ‘‘Are results from lasers’ rat
skin penetration applicable to humans?’’ Few LLLT-studies
are concerned with sequelae in the skin during irradiation
aiming at tissues beneath the skin. This might be because of
the absence of side effects such as skin damage or ablation
from LLLT treatment.3 To the latter issue, the photoacceptor
processes from irradiation by near infrared light are believed
to be the same in all mammalian cells, catalyzed by cyto-
chrome c oxidase.29 Stratum corneum and skin thickness in
both rats30 and humans31 differs with body site. Most irra-
diation of the skin is absorbed or scattered in stratum cor-
neum of epidermis,32 and there is considerable similarity in
this skin layer thickness between rats30 and humans.31 On
the other hand, within the research areas of photodynamic
therapy and drug metabolisms, the degree of skin perme-
ability and percutaneous absorption differs between rats and
humans.33–36 Further histology investigations after single
and repeated LLLT irradiation of rat and human skin flaps
are recommended to elucidate if the observed changes over
time in 904 nm penetration are irreversible or permanent.
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